EuroPCR 2025 is now over
For those of you who joined us in Paris, thank you for attending. We were happy to have you with us and we hope to see you again next year. For those of you who attended remotely, we hope to see you next year, whether in person or online.
Please help us keep improving our Press service by contacting us with any suggestions for improvement.
The Press Portal will stay live until Friday 20 June 2025.
- 2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James
- EuroPCR 2025 – The place to share solutions
- The RESIL-Card project is piloting its resilience assessment tool across Europe
- EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose
- EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI
- EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials
Course content is available online via the Course platform for one month after EuroPCR for journalists who attended #EuroPCR in person or digitally. The slide presentations will be available on PCRonline.
For a wide range of topics and interviews from EuroPCR 2025, click here.
If you missed out on one at the Course there’s still time for you to have a look at it!
For any press-related inquiries, please contact us:
PCR Press Coordinator
Isabelle UZIELLI
